Probiotics for cardiometabolic health: the key to stronger hearts
Healthy gut, happy heart
Science shows that the gut bacteria may influence several molecules linked to lipid metabolism, which is closely linked to cholesterol.1,2 Unbalanced microbiome diversity has been associated with high cholesterol-related diseases, like cardiovascular disease and obesity.3,4 While cholesterol is necessary for various bodily functions, excessive levels of “bad” cholesterol and lipids can contribute to the build up of plaque in the arteries, increasing the risk of heart disease, heart attacks and strokes.
We have characterized the mechanism of action in our probiotic solutions to deliver targeted cardiometabolic health solutions – proven to reduce cholesterol and support successful and safe weight loss.
Probiotic solutions for Cardiometabolic health
AB-LIFE
1.2 billion CFU/dose
Indications
- Atheroprotective effects
- Hypercholesterolemia and hypertriglyceridemia
- Maintains a healthy blood lipid profile
Probiotic Strains
- L. plantarum KABP™ 011
- L. plantarum KABP™ 012
- L. plantarum KABP™ 013
Formats
Capsules, sticks, drops
LipiGO®
3000 mg/dose
Indications
- Prevents rebound effect
- Safe weight loss
- Overweight and type I obesity
Probiotic Strains
- Saccharomyces cerevisiae postbiotic (BGCC extract)
Formats
Sticks
- Tang, W. H. W., Kitai, T. & Hazen, S. L. Gut microbiota in cardiovascular health and disease. Circulation Research vol. 120 1183–1196 (2017).
- Herrema, H, Nieuwdorp, M. & Groen, A. K. Microbiome and Cardiovascular Disease. Handb Exp Pharmacol (2020).
- Karlsson, F. H. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, (2012).
- Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: Human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
